Angelalign H1 Revenue Jumps 43% as International Business Turns Profitable

Angelalign Technology Inc. (HKEX: 6699) reported significant growth in its first-half financial results, with revenue climbing 42.9% year-over-year to $231 million, driven by a surge in clear aligner cases and the pivotal achievement of profitability in its international division. The company's total case volume reached 316,609, a 40.2% increase from the same period last year, according to its latest financial report.

International Expansion Reaches Profitability

The company's international operations have emerged as a core growth engine, achieving profitability for the first time. This marks a significant milestone, suggesting Angelalign's global expansion strategy is transitioning from a high-investment phase to a period of sustainable returns.

Key figures from its global business (excluding mainland China) for the first half include:

• Case Volume: Reached 168,000, a year-over-year increase of 43.4%.
• Revenue Contribution: International markets now account for over 50% of the company's total cases and revenue.

This turnaround is attributed to the scaling of its global direct sales network and achieving greater operating leverage. The company has focused on building localized teams and engaging with dental professionals through academic conferences in Europe, North America, Latin America, and the Asia-Pacific region.

Domestic Market Share Gains

Ad

While global expansion accelerates, Angelalign continues to strengthen its leading position in mainland China. The company saw its domestic case volume grow by 36.8% to 148,608 in the first half of the year.

Growth in China is increasingly driven by deeper penetration into lower-tier cities. According to the report, this expansion is based on providing extensive clinical support and training for orthodontists, which helps build trust and enhances their ability to handle complex cases, thereby unlocking new demand.

Strategic Outlook

The strong interim results underscore the effectiveness of Angelalign's dual-engine growth strategy, which combines robust domestic market leadership with accelerating international expansion. By proving its business model is profitable on a global scale, the company is solidifying its position as a key competitor in the international clear aligner market.

For investors, this performance demonstrates a more balanced and resilient global growth structure. The company's ability to convert its clinical expertise and operational scale into market share and profitability, both at home and abroad, signals a new phase in its development from a regional leader to a global contender.